Patten CJ - Search Results

1

Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6.

Court MH, Almutairi FE, Greenblatt DJ, Hazarika S, Sheng H, Klein K, Zanger UM, Bourgea J, Patten CJ, Kwara A. Court MH, et al. Among authors: patten cj. Antimicrob Agents Chemother. 2014 Jul;58(7):4145-52. doi: 10.1128/AAC.02532-14. Epub 2014 May 12. Antimicrob Agents Chemother. 2014. PMID: 24820076 Free PMC article.

2

Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.

Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, Greenblatt DJ. Court MH, et al. Among authors: patten cj. Drug Metab Dispos. 2003 Sep;31(9):1125-33. doi: 10.1124/dmd.31.9.1125. Drug Metab Dispos. 2003. PMID: 12920168

3

Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.

Wang J, Williams ET, Bourgea J, Wong YN, Patten CJ. Wang J, et al. Among authors: patten cj. Drug Metab Dispos. 2011 Aug;39(8):1329-33. doi: 10.1124/dmd.111.039628. Epub 2011 May 3. Drug Metab Dispos. 2011. PMID: 21540359

4

Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.

Stresser DM, Broudy MI, Ho T, Cargill CE, Blanchard AP, Sharma R, Dandeneau AA, Goodwin JJ, Turner SD, Erve JC, Patten CJ, Dehal SS, Crespi CL. Stresser DM, et al. Among authors: patten cj. Drug Metab Dispos. 2004 Jan;32(1):105-12. doi: 10.1124/dmd.32.1.105. Drug Metab Dispos. 2004. PMID: 14709627

5

New technologies for assessing UDP-glucuronosyltransferase (UGT) metabolism in drug discovery and development.

Patten CJ. Patten CJ. Drug Discov Today Technol. 2006 Spring;3(1):73-8. doi: 10.1016/j.ddtec.2006.03.007. Drug Discov Today Technol. 2006. PMID: 24980104

6

Glucuronides of tea catechins: enzymology of biosynthesis and biological activities.

Lu H, Meng X, Li C, Sang S, Patten C, Sheng S, Hong J, Bai N, Winnik B, Ho CT, Yang CS. Lu H, et al. Drug Metab Dispos. 2003 Apr;31(4):452-61. doi: 10.1124/dmd.31.4.452. Drug Metab Dispos. 2003. PMID: 12642472

7

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.

Zhang D, Chando TJ, Everett DW, Patten CJ, Dehal SS, Humphreys WG. Zhang D, et al. Among authors: patten cj. Drug Metab Dispos. 2005 Nov;33(11):1729-39. doi: 10.1124/dmd.105.005447. Epub 2005 Aug 23. Drug Metab Dispos. 2005. PMID: 16118329

8

A high-throughput screen to identify inhibitors of aromatase (CYP19).

Stresser DM, Turner SD, McNamara J, Stocker P, Miller VP, Crespi CL, Patten CJ. Stresser DM, et al. Among authors: patten cj. Anal Biochem. 2000 Sep 10;284(2):427-30. doi: 10.1006/abio.2000.4729. Anal Biochem. 2000. PMID: 10964434 No abstract available.

9

Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay.

Kragie L, Turner SD, Patten CJ, Crespi CL, Stresser DM. Kragie L, et al. Among authors: patten cj. Endocr Res. 2002 Aug;28(3):129-40. doi: 10.1081/erc-120015045. Endocr Res. 2002. PMID: 12489563

10

Comparison of species differences of P-glycoproteins in beagle dog, rhesus monkey, and human using Atpase activity assays.

Xia CQ, Xiao G, Liu N, Pimprale S, Fox L, Patten CJ, Crespi CL, Miwa G, Gan LS. Xia CQ, et al. Among authors: patten cj. Mol Pharm. 2006 Jan-Feb;3(1):78-86. doi: 10.1021/mp050034j. Mol Pharm. 2006. PMID: 16686372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters